Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Haemonetics 2nd Quarter and First Half Fiscal 2020 Earnings Release Available on Investor Relations Website

HAE

Release accessible online

BRAINTREE, Mass., Nov. 1, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter and first half of fiscal 2020, which ended Sept. 28, 2019, are available on its Investor Relations website.

The Company is posting the earnings release and results tables that will be referenced on its webcast to its Investor Relations website. 

Direct link to Earnings Release 2Q FY20:

https://haemonetics.gcs-web.com/static-files/a39d5807-57c1-4454-9081-1c99522dcd10

Direct link to Results Tables 2Q FY20 That Will Be Referenced on Webcast:

https://haemonetics.gcs-web.com/static-files/9f44beab-8d3f-46d0-b05d-26ce8a6ec198

The Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8 a.m. ET on Nov. 1, 2019. The call can be accessed with the following information:

  • U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
  • Conference ID required for access: 9166003
  • A live webcast of the call can be accessed on Haemonetics' investor relations website.
  • Direct link to Conference Call Webcast: https://edge.media-server.com/mmc/p/upf9m2nz

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.      

Investor Contact                                        

Media Contact

Olga Guyette, Sr. Mgr.-Investor Relations                

Carla Burigatto, VP-Communications

(781) 356 9763

(781) 348-7263

olga.guyette@haemonetics.com                        

carla.burigatto@haemonetics.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-and-first-half-fiscal-2020-earnings-release-available-on-investor-relations-website-300949576.html

SOURCE Haemonetics Corporation



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today